NCT07005154 2026-04-02A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate CancerAstellas Pharma IncPhase 2 Recruiting218 enrolled
NCT04034095 2025-12-15A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in JapanJanssen Pharmaceutical K.K.Completed979 enrolled
NCT05288166 2025-06-27CYCLONE 3Eli Lilly and CompanyPhase 3 Active not recruiting925 enrolled 12 charts